Found 20 matching trials
Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
PHASE3This trial is designed to assess the safety and efficacy of flibanserin in ...
Location
511.75.01015 Boehringer Ingelheim Investigational Site
Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America
PHASE3The objective of this trial is to assess the safety and efficacy of 24-week...
Location
511.156.01059 Boehringer Ingelheim Investigational Site
Hypoactive Sexual Desire Disorder in Males
PHASE2The purpose of this study is to determine if the study drug will increase s...
Location
Baylor College of Medicine
6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA
PHASE3This trial is designed to assess the safety and efficacy of flibanserin in ...
Location
511.70.01068 Boehringer Ingelheim Investigational Site
24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
PHASE3This trial is designed to assess the safety and efficacy of flibanserin in ...
Location
511.71.01034 Boehringer Ingelheim Investigational Site
A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).
PHASE3To determine if long-term treatment with Flibanserin is safe and to monitor...
Location
511.84.01079 Boehringer Ingelheim Investigational Site
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer
PHASE2This is a double-blinded, placebo-controlled randomized phase II clinical t...
Location
University of Alabama at Birmingham
A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors
PHASE2The purpose of this study is to determine if it is feasible for women to ta...
Status
Active Not Recruiting
A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder
PHASE3To generate additional long-term safety and efficacy data on flibanserin in...
Location
511.133.01074 Boehringer Ingelheim Investigational Site
Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
PHASE3The object of this trial is to assess the safety and efficacy of a 24 week ...
Location
511.147.01074 Boehringer Ingelheim Investigational Site